US Patent Issued to BIOPHYTIS, SORBONNE UNIVERSITE on Oct. 14 for "Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases" (French Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,500, issued on Oct. 14, was assigned to BIOPHYTIS (Paris) and SORBONNE UNIVERSITE (Paris).

"Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases" was invented by Mathilde Latil (Paris), Pierre Dilda (Paris), Rene Lafont (Paris) and Stanislas Veillet (Savigny sur Orge, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are 20-hydroxyecdysone and the derivatives thereof, intended for use in the treatment of a neuromuscular disease such as spinal muscular atrophy or amyotrophic lateral sclerosis, or more particularly in the treatment of a specific disorder of the motor neurons causing alterations in...